Assessment of individual tumor‐level data indicates that HR alterations are not mutually exclusive, and the most frequently altered HR gene is NBN (22%), while BRCA1 and BRCA2 are altered in ~ 7 and 8% of these tumors, respectively (Fig 6D). The gene discussed is BRCA2; the disease is neoplasm.